CELLRX Trademark

Trademark Overview

On Monday, August 18, 2025, a trademark application was filed for CELLRX with the United States Patent and Trademark Office. The USPTO has given the CELLRX trademark a serial number of 99342961. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Thursday, January 8, 2026. This trademark is owned by CellRx LLC. The CELLRX trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical services, namely, cellular maximal optimization, including, namely, stem cell injections and intravenous stem cell administration, peptide treatments, hormone replacement therapy, and lifestyle and nutrition counseling
cellrx

General Information

Serial Number99342961
Word MarkCELLRX
Filing DateMonday, August 18, 2025
Status680 - APPROVED FOR PUBLICATION
Status DateThursday, January 8, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical services, namely, cellular maximal optimization, including, namely, stem cell injections and intravenous stem cell administration, peptide treatments, hormone replacement therapy, and lifestyle and nutrition counseling
Pseudo MarkCELL RX

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 18, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCellRx LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLehi, UT 84048

Trademark Events

Event DateEvent Description
Monday, August 18, 2025NEW APPLICATION ENTERED
Monday, August 18, 2025APPLICATION FILING RECEIPT MAILED
Sunday, January 4, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 5, 2026ASSIGNED TO EXAMINER
Thursday, January 8, 2026APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

cellrx stem cell namely treatments replacement hormone therapy counseling nutrition lifestyle